Form 4: Pfizer Director Echevarria Acquires Phantom Stock Units as Deferred Compensation

Director Joseph Echevarria acquired 8,999 phantom stock units of Pfizer Inc. as part of a deferred compensation plan.

Summary

• On April 24, 2025, Joseph Echevarria, a director of Pfizer Inc., acquired 8,999 phantom stock units.
• The acquisition was made pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
• Each unit represents one phantom share of common stock.
• These units represent deferred director's compensation that are settled in cash or common stock at the director's election following retirement from the Board of Directors.
• Following the transaction, Echevarria beneficially owns 136,452.425 phantom stock units directly.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment as it aligns director interests with company performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of Pfizer.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors.

Industry Context

Director compensation packages often include stock-based awards to incentivize performance and align interests with shareholders. Phantom stock units are a common form of deferred compensation for non-employee directors.

Comparison to Industry Standards

• Director compensation packages vary across the pharmaceutical industry.
• Companies like Johnson & Johnson (JNJ) and Merck (MRK) also utilize stock options, restricted stock units, and deferred compensation plans for their directors.
• The specific terms and amounts of these awards depend on factors such as company size, performance, and industry benchmarks.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates

Keywords

phantom stock units, director compensation, deferred compensation, Form 4, Pfizer, Echevarria, PFE